324 related articles for article (PubMed ID: 16691103)
1. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.
Kellerer AM; Rühm W; Walsh L
Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103
[TBL] [Abstract][Full Text] [Related]
2. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.
Rühm W; Walsh L
Radiat Prot Dosimetry; 2007; 126(1-4):423-31. PubMed ID: 17533156
[TBL] [Abstract][Full Text] [Related]
3. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
Preston DL; Pierce DA
Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
[TBL] [Abstract][Full Text] [Related]
4. Accounting for neutron exposure in the Japanese atomic bomb survivors.
Cullings HM; Pierce DA; Kellerer AM
Radiat Res; 2014 Dec; 182(6):587-98. PubMed ID: 25409123
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk estimates for gamma-rays with regard to organ-specific doses Part II: site-specific solid cancers.
Walsh L; Rühm W; Kellerer AM
Radiat Environ Biophys; 2004 Dec; 43(4):225-31. PubMed ID: 15645312
[TBL] [Abstract][Full Text] [Related]
6. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer risk in mice: analysis of fractionation effects and neutron RBE with a biologically motivated model.
Heidenreich WF; Carnes BA; Paretzke HG
Radiat Res; 2006 Nov; 166(5):794-801. PubMed ID: 17067205
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk estimates for gamma-rays with regard to organ-specific doses. Part I: All solid cancers combined.
Walsh L; Rühm W; Kellerer AM
Radiat Environ Biophys; 2004 Sep; 43(3):145-51. PubMed ID: 15309386
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors.
Cordova KA; Cullings HM
Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313
[TBL] [Abstract][Full Text] [Related]
10. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
Little MP
Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
[TBL] [Abstract][Full Text] [Related]
11. Risk coefficient for gamma-rays with regard to solid cancer.
Kellerer AM; Walsh L; Nekolla EA
Radiat Environ Biophys; 2002 Jun; 41(2):113-23. PubMed ID: 12201054
[TBL] [Abstract][Full Text] [Related]
12. Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.
Walsh L
Radiat Environ Biophys; 2013 Mar; 52(1):29-36. PubMed ID: 23161400
[TBL] [Abstract][Full Text] [Related]
13. Neutrons at Hiroshima: how their disappearance affected risk estimates.
Ellett WH
Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
[TBL] [Abstract][Full Text] [Related]
14. Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors.
Hafner L; Walsh L; Rühm W
Int J Radiat Biol; 2024; 100(1):61-71. PubMed ID: 37772764
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
Schneider U; Walsh L
Radiat Environ Biophys; 2008 Apr; 47(2):253-63. PubMed ID: 18157543
[TBL] [Abstract][Full Text] [Related]
16. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992.
Delongchamp RR; Mabuchi K; Yoshimoto Y; Preston DL
Radiat Res; 1997 Mar; 147(3):385-95. PubMed ID: 9052687
[TBL] [Abstract][Full Text] [Related]
17. Stable chromosome aberrations among A-bomb survivors: an update.
Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
[TBL] [Abstract][Full Text] [Related]
18. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
[TBL] [Abstract][Full Text] [Related]
19. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
Kellerer AM; Nekolla E
Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
[TBL] [Abstract][Full Text] [Related]
20. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]